Downloadable tables: Antimicrobial consumption – Annual Epidemiological Report for 2016

table
Period: 01 Jan 2016 - 31 Dec 2016

Data from the 'Antimicrobial consumption - Annual Epidemiological Report for 2016'.

Available tables

Table D1. Trends in consumption of tetracyclines (ATC group J01A) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D2. Trends in consumption of beta-lactam antibacterials, penicillins (ATC group J01C) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D3. Trends in consumption of other beta-lactam antibacterials (ATC group J01D) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D4. Trends in consumption of sulfonamides and trimethoprim (ATC group J01E) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D5. Trends in consumption of macrolides, lincosamides and streptogramins (ATC group J01F) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D6. Trends in consumption of quinolone antibacterials (ATC group J01M) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D7. Trends in consumption of other antibacterials (ATC group J01X) in the community, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D8. Consumption of antibacterials for systemic use (ATC group J01) by ATC group level 3 in the community, EU/EEA countries, 2016, expressed as packages per 1 000 inhabitants per day

Table D9. Trends in consumption of antibacterials for systemic use (ATC group J01) in the community, EU/EEA countries, 2012–2016, expressed as packages per 1 000 inhabitants per day

Table D10. ESAC quality indicators for consumption data of antibacterials for systemic use (ATC group J01), for the community, EU/EEA countries, 2016

Table D11. Consumption of oral vancomycin (A07AA09), rifampicin (J04AB02) and oral and rectal metronidazole (P01AB01) in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day

Table D12. Trends in consumption of carbapenems (ATC group J01DH) in the hospital sector, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D13. Trends in consumption of polymyxins (ATC group J01XB) in the hospital sector, EU/EEA countries, 2012–2016, expressed as DDD per 1 000 inhabitants per day

Table D14. Consumption of oral vancomycin (A07AA09), rifampicin (J04AB02) and oral and rectal metronidazole (P01AB01) in the hospital sector, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day 

Table D15. Consumption of antimycotics (ATC group J02) and antifungals (ATC group D01B) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day

Table D16. Consumption of antimycotics (ATC group J02) and antifungals (ATC group D01B) for systemic use in the hospital sector, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day

Table D17. Consumption of antivirals for systemic use (ATC group J05) in both sectors (community and hospital sector), EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day

Erratum: on 28 June 2018 values were updated for the antivirals in the columns J05AF, J05AG, J05AH, J05AX and the totals (J05) for the following countries: Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Spain, Finland, Croatia, Ireland, Iceland, Italy, Lithuania, Latvia, Portugal, Sweden, Slovenia and the EU/EEA 

Table D18. Consumption of antivirals for systemic use (ATC group J05) in both sectors (community and hospital sector), grouped into categories of their main indication, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day

Erratum: on 28 June 2018 values were adapted in the columns hepatitis B antivirals, hepatitis C antivirals, HIV/AIDS antivirals, influenza antivirals and total for Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Spain, Finland, Croatia, Ireland, Iceland, Italy, Lithuania, Latvia, Portugal, Sweden, Slovenia and the EU/EEA.

Related publications

See all Annual Epidemiological Reports for 2016

Publication

Cholera - Annual Epidemiological Report for 2016

surveillance report -

Publication

Echinococcosis - Annual Epidemiological Report for 2016

surveillance report -

Publication

Smallpox - Annual Epidemiological Report for 2016

surveillance report -

Publication

Zika virus infection - Annual Epidemiological Report for 2016

surveillance report -

Publication

Lassa fever- Annual Epidemiological Report for 2016

surveillance report -